FK228重塑瘤微环境,以增强抗PD-L1疗效
Liang Gong1,2, Lu Tian1,3, He Li2,3
1College of Synthetic Biology Industry, Center for Cell and Gene Therapy Research, Hunan University of Arts and Science, Changde, Hunan, China.
Oncogene
|September 12, 2025
概括
基因组脱乙酶抑制剂FK228通过诱导亡和重编程瘤免疫微环境 (TIME) 来增强抗癌免疫力. 将FK228与PD-L1阻断相结合有效地延缓瘤生长,并改善小鼠的生存率.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 固体瘤中对免疫检查点阻塞 (ICB) 的有限反应与不利的瘤免疫微环境 (TIME) 有关.
- 需要新的策略来提高ICB在固体瘤中的疗效.
研究的目的:
- 为了研究FK228的潜力,一个组织素脱乙酶抑制剂,作为ICB敏感剂在固体瘤中.
- 阐明FK228调节时间的机制.
主要方法:
- 评估FK228是否能够在癌细胞中诱导亡和内分泌网膜应激.
- 评估了FK228在时间内对免疫细胞透和表型 (CD8+T细胞,NK细胞,巨细胞) 的影响.
- 使用FK228和PD-L1抑制剂的联合治疗在小鼠瘤模型中进行了测试.
主要成果:
- FK228通过触发内质网膜应激作用,作为亡诱导剂,增强癌细胞免疫性.
- FK228增加了杀伤瘤免疫细胞的透和激活,包括CD8+ T细胞和NK细胞.
- 在小鼠中,FK228治疗促进了亲炎性巨细胞表型,并且在与PD-L1阻断相结合时,显著延迟了瘤生长和延长了生存时间.
结论:
- 在固体瘤中,FK228显示出作为免疫检查点阻塞的新型敏感剂的潜力.
- 基因组脱乙酶抑制在克服免疫抑制的时间方面发挥着至关重要的作用.
- 重用FK228为固体瘤治疗提供了新的治疗可能性.
更多相关视频
09:32Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
Published on: February 8, 2018
15.4K
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
1.7K
相关概念视频
01:27Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
02:17The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K